U.S. and E.U. orphan drug designation granted to Vivet's gene therapy VTX-801 for Wilson's disease Sep. 26, 2017
Phase III trial of somavaratan in pediatric growth hormone deficiency does not meet primary endpoint Sep. 22, 2017
RSS